Cell Biology – Immunology – Pathology
Kidney International (2004) 65, 490–499; doi:10.1111/j.1523-1755.2004.00413.x
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-
GANESAN RAMESH and W BRIAN REEVES
Division of Nephrology, The Penn State College of Medicine, Hershey, Pennsylvania; and Lebanon VA Medical Center, Lebanon, Pennsylvania
Correspondence: W. Brian Reeves M.D., Division of Nephrology, H040, Penn State College of Medicine, 500 University Dr., Hershey, PA 17033. E-mail:Wreeves@psu.edu
Received 10 April 2003; Revised 24 July 2003; Re-revised 30 August 2003; Accepted 22 September 2003.
Abstract
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-
.
Background
Salicylate was recently shown to provide protection against cisplatin nephrotoxicity in rats. We have demonstrated that enhanced tumor necrosis factor-
(TNF-
) production mediates, in part, cisplatin nephrotoxicity. The purpose of this study was to determine if the protective effects of salicylate were mediated through inhibition of TNF-
in vivo and to explore the mechanism of inhibition in vitro.
Methods
The effects of treatment with cisplatin alone and in combination with sodium salicylate in mice on renal function, histology, and gene expression were determined. The effects of cisplatin and salicylate on TNF-
expression, nuclear factor kappa B (NF-
B) activity, and apoptosis were determined in vitro using cultured murine proximal tubule cells.
Results
Salicylate significantly reduced both the functional and histologic evidence of cisplatin renal injury. Cisplatin increased the renal expression of TNF-
, monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule (ICAM)-1, heme oxygenase-1, TNF receptor 1 (TNFR1), and TNF receptor 2 (TNFR2). Treatment with sodium salicylate blunted the increase in TNF-
mRNA and also reduced serum TNF-
protein levels. Salicylate had little protective effect when administered with cisplatin to TNF-
–deficient mice. Cisplatin increased the degradation of I kappa B (I
B) in a time-dependent manner and also increased nuclear NF-
B binding activity. Salicylate inhibited I
B degradation and NF-
B binding activity in the presence of cisplatin. In addition, salicylate inhibited the cisplatin induced TNF-
mRNA increase in mouse proximal tubule epithelial (TKPT) cells.
Conclusion
These results indicate that salicylate acts via inhibition of TNF-
production to reduce cisplatin nephrotoxicity. The inhibition of TNF-
production may be mediated via stabilization of I
B.
Keywords:
acute tubular necrosis, gene expression, I
B, NF-
B, tumor necrosis factor receptor, cytokines
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Therapy Insight: the use of antirheumatic drugs during nursing
Nature Clinical Practice Rheumatology Review (01 Jul 2007)
Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases
Nature Clinical Practice Rheumatology Review (01 Sep 2007)
NEWS AND VIEWS
Janus faces of NF-κB: Neurodestruction versus neuroprotection
Nature Medicine News and Views (01 Jan 1997)
RESEARCH
Inflammatory cytokines in acute renal failure
Kidney International Original Article
Kidney International Original Article


